VIEW WEBSITE >>
1 known investors
Slate Bio develops regulatory T cell (Treg) therapies for treating autoimmune diseases. The company focuses on advancing immunology treatments for patients with autoimmune conditions.
BiotechDigital HealthMedical Devices